Changes in miRNA expression in sera and correlation to duration of disease in patients with multifocal mucosal lichen planus

Journal of Oral Pathology and Medicine

Volumn 41, Issue 1, 2012, Pages 86-89

  Nylander, Elisabet ^a   Ebrahimi, Majid ^a   Wahlin, Ylva Britt ^a   Boldrup, Linda ^a   Nylander, Karin ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

MiRNA; Multifocal mucosal lichen planus

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LICHEN PLANUS; MALE; MOUTH CARCINOMA; MULTIFOCAL MUCOSAL LICHEN PLANUS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; APOPTOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LICHEN PLANUS; LICHEN PLANUS, ORAL; MALE; MICRORNAS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, UNTRANSLATED; SIMPLEXVIRUS; TIME FACTORS; UP-REGULATION;

EID: 84855470057     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01063.x     Document Type: Article

References (18)

1. Scully G, El-Kom M. Lichen planus:review and update on pathogenesis. J Oral Pathol 1985; 14: 431-58.
2. Nylander Lundqvist E, Wahlin YB, Bergdahl M, Bergdahl J. Psychological health in patients with genital and oral erosive lichen planus. J Eur Acad Dermatol Venereol 2006; 20: 661-6.
3. Arndt KA. Lichen planus. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al. eds Dermatology in General Medicine. New York: McGraw -Hill, 1987; 967-73.
4. Sugerman PB, Savage NW, Walsh LJ, et al. Disease mechanisms in oral lichen planus. A possible role for autoimmunity. Australas J Dermatol 1993; 34: 63-9.
5. Van Der Meij EH, Mast H, Van Der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol 2007; 43: 742-8.
6. Meltzer PS. Small RNAs with big impact. Cancer Genomics 2005; 435: 745-6.
7. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-73.
8. Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 2009; 35: 339-47.
9. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009; 285: 116-26.
10. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-5.
11. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008; 14: 2588-92.
12. Brase JC, Johannes M, Schlomm T, et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 2011; 128: 608-16.
13. Kong X, Du Y, Wang G, et al. Detection of differentially expressed miRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci 2011; 56: 602-9. Epub 2010 Jul 8.
14. Wang F, Zheng Z, Guo J, Ding X. Correlation and quantitation of micrRNA aberrant expression in tissue and sera from patients with breast tumor. Gynecol Oncol 2010; 119: 586-93.
15. Ebrahimi M, Wahlin YB, Coates PJ, Wiik A, Roos G, Nylander K. Detection of antibodies against p63 and p73 isoforms in sera from patients diagnosed with oral lichen planus. J Oral Pathol Med 2007; 36: 93-8.
16. Yan LX, Huang XF, Shao Q, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008; 14: 2348-60.
17. Zhao Y, Srivastava D. A developmental view of microRNA function. Trends Biochem Sci 2007; 32: 189-97.
18. Erson AE, Petty EM. MicroRNAs in development and disease. Clin Genet 2008; 74: 296-306.